See all locations for this study
Phase 1Recruiting

Treatment of Moderate to Severe Refractory Crohn's Disease

Sponsored by Tr1X, Inc.

About this study

This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.

Enrolling at this location

University of California, San Francisco

San Francisco, California

I'm interested

This study also enrolls at 12 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.